3B Blackbio Diagnostics Ltd. (3BBLACKBIO)
Market Closed
15 Oct, 10:00 PM
MSE XNSE Primary MSE ₹
1,459. 90
-4.9
-0.3345%
₹
9.91B Market Cap
- P/E Ratio
4% Div Yield
1,530 Volume
- Eps
₹ 1,464.8
Previous Close Want to track 3BBLACKBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
3BBLACKBIO closed today lower at ₹1,459.9, a decrease of -0.3345% from yesterday's close, completing a monthly decrease of -13.6639% or -₹231.05. Over the past 12 months, 3BBLACKBIO stock gained 4.2748%.
3BBLACKBIO pays dividends to its shareholders, with the most recent payment made on Oct 05, 2026. The next estimated payment will be in In 11 months on Oct 05, 2027 for a total of ₹5.
The last earnings report, released on Jun 03, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).
3B Blackbio Diagnostics Ltd. (3BBLACKBIO) FAQ
What is the stock price today?
The current price is ₹1,459.90.
On which exchange is it traded?
3B Blackbio Diagnostics Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is 3BBLACKBIO.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 4%.
What is its market cap?
As of today, the market cap is 9.91B.
Has 3B Blackbio Diagnostics Ltd. ever had a stock split?
No, there has never been a stock split.
3B Blackbio Diagnostics Ltd. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | - CEO | MSE Exchange | INE994E01018 ISIN |
| India Country | 85 Employees | - Last Dividend | - Last Split | - IPO Date |
3B Blackbio Diagnostics Ltd. is a biotechnology and diagnostics company focused on providing innovative solutions in the field of molecular diagnostics. Its core activity revolves around the development and commercialization of diagnostic test kits that are essential for identifying various infectious diseases, genetic disorders, and oncology markers. With a strong emphasis on research and development, 3B Blackbio Diagnostics Ltd. has established itself within the healthcare and medical research sectors by delivering high-quality, reliable diagnostic tools that cater to both domestic and international markets. The company plays a vital role in facilitating rapid disease diagnosis, which in turn supports more efficient and targeted treatment plans. By doing so, 3B Blackbio Diagnostics Ltd. contributes significantly to the advancement of personalized medicine and public health efforts, underscoring its importance in the healthcare industry.
Contact Information
Address: 7-C, Industrial Area
Phone: 91 75 5258 6536
Website: https://3bblackbio.com
2026 © Marketlog. All Rights Reserved.
